Petco Health and Wellness Company, Inc.

WOOF Consumer Cyclical Specialty Retail

Petco Health and Wellness Company, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $6.0 billion, down 2.53% from fiscal 2025. In the quarter to July 2026, revenue was flat, EPS grew 180.0%, free cash flow grew 136.5% and total debt fell 6.98%, each against the same quarter a year earlier.

2.33 0.06 −2.51%
Market cap
$683.1M
P/E
21.2×
Fwd P/E
32.0×
Dividend yield
—
F-score
7/9
Altman Z
1.01
Beneish M
−2.62
Dividend safety
n/a

Insider Decisions trades per month

Total sells 1.72
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — 1 — — 1 — — — 2 — — —
Insider Ownership 48.05%

Capital & Financial Ratios $m

Market Cap 683.11
Revenue 5,965.49
Net Income 30.27
Free Cash Flow 237.94
Net Debt 1,181.93
Current Ratio 0.90 (below 1: weak)
Debt/Equity 1.22
P/E ratio 21.18
Fwd P/E 32.00
P/S ratio 0.11
P/B ratio 0.55
Past 5Y EPS Growth —
This Y EPS Growth 49.08% (at or above 15%: strong)
Next Y EPS Growth 0.62%
Next Y revenue growth 0.48%
Next 5Y EPS Growth 18.28% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 3.09%
10-year low 10-year high
P/S against its own 10 years 7.68%
10-year low 10-year high
P/B against its own 10 years 6.78%
10-year low 10-year high
EV/Sales against its own 10 years 2.28%
10-year low 10-year high
EV/FCF against its own 10 years 1.40%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2026 Powerpack
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2024 2025 2026 Q'26
Cash 125 166 257 293
Receivables 44 40 46 38
Inventory 685 653 590 602
Other 39 61 75 65
952 974 1,020 1,053
2024 2025 2026 Q'26
Payables 485 493 451 455
ST’ Debt 16 5 5 12
Other — — — —
1,113 1,139 1,134 1,166

Compound Annual Growth %

10y 5y 3y
Sales — 3.91% (0.41%)
Cash Flow — 3.17% (3.18%)
Earnings — 0.00% (53.61%)
Book Value — (10.74%) (21.22%)

Revenue $m

Apr Jul Oct Jan Year
’26 1,497 1,489 — — —
’26 1,493 1,489 1,464 1,515 5,961
’25 1,529 1,524 1,511 1,552 6,116
’24 1,556 1,531 1,494 1,674 6,255
’23 1,476 1,481 1,501 1,578 6,036
’22 1,415 1,435 1,443 1,514 5,807
’21 1,114 1,209 1,260 1,338 4,920
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Apr Jul Oct Jan Year
’26 (31) 162 — — —
’26 (15) 86 90 154 314
’25 (8) 69 21 96 178
’24 38 97 34 47 216
’23 58 43 109 137 346
’22 115 87 86 70 358
’21 (32) 125 109 67 269
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Apr Jul Oct Jan Year
’26 (69) 130 — — —
’26 (43) 55 61 116 189
’25 (41) 43 (10) 59 51
’24 (24) 45 (28) (2) (10)
’23 (8) (26) 33 71 70
’22 68 35 22 (5) 119
’21 (60) 104 63 6 112
Fiscal quarters ending in the months shown.

EPS $

Apr Jul Oct Jan Year
’26 (0.05) 0.13 — — —
’26 (0.04) 0.05 0.03 (0.01) 0.03
’25 (0.17) (0.09) (0.06) (0.05) (0.37)
’24 (0.01) (0.05) (4.63) (0.08) (4.78)
’23 0.09 0.05 0.07 0.12 0.34
’22 0.03 0.28 0.20 0.11 0.62
’21 (0.16) 0.03 0.01 (0.03) (0.13)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.9
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to January

Group Line 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Trend 2027e 2028e 2029e
Price, $
Price, $ Low — — — — 17.82 8.72 2.63 1.41 2.28 2.14

Analyst estimates 2027–2029

Powerpack
High — — — — 31.08 22.75 12.58 6.29 4.51 3.78
People
People Employees — — — — 27,081 28,495 29,000 29,000 29,000 29,000
Revenue/emp, $m — 0.00 0.00 0.00 0.18 0.20 0.21 0.22 0.21 0.21
Income, $m
Income, $m Revenue — 4,392 4,392 4,435 4,920 5,807 6,036 6,255 6,116 5,961
Gross margin, % — 43.37 43.37 42.99 42.82 41.79 40.21 37.63 38.00 38.67
EBT — (459) (1,796) (142) (42) 202 112 (1,324) (128) (5)
EBT margin, % — (10.44) 0.00 (3.20) (0.84) 3.49 1.86 (21.17) (2.09) (0.08)
Net income — (414) 0 (104) (32) 160 90 (1,280) (102) 9
Depreciation — 583 147 216 199 178 199 1,431 213 202
Per share, $
Per share, $ Revenue — 0.00 21.03 21.22 23.35 21.98 22.73 23.38 22.37 21.32
Earnings — — (1.98) (0.50) (0.13) 0.62 0.34 (4.78) (0.37) 0.03
Cash flow — 0.00 0.00 0.53 1.28 1.36 1.30 0.81 0.65 1.12
Capex — 0.00 0.00 (0.75) (0.74) (0.90) (1.04) (0.84) (0.46) (0.45)
Free cash flow — 0.00 0.00 (0.22) 0.53 0.45 0.26 (0.04) 0.19 0.68
Book value — 0.00 3.05 2.69 9.76 8.54 8.97 4.43 4.07 4.16
Shares, m — — 209 209 211 264 266 268 273 280
Valuation, ×
Valuation, × P/E — 0.00 0.00 0.00 0.00 30.24 35.42 0.00 0.00 90.67
P/S — 1.30 1.30 1.30 1.09 0.85 0.51 0.10 0.15 0.13
P/B — 11.26 11.26 11.26 2.61 2.20 1.30 0.54 0.84 0.65
EV/Sales — 1.94 1.94 1.94 1.40 1.10 0.75 0.34 0.38 0.33
EV/FCF — 38.58 38.58 38.58 22.71 53.68 64.75 (213.20) 46.09 10.54
Cash, $m
Cash, $m Operating cash flow — 203 60 110 269 358 346 216 178 314
Capex — (148) (119) (157) (156) (239) (276) (226) (127) (125)
Free cash flow — 55 (59) (47) 112 119 70 (10) 51 189
Balance, $m
Balance, $m Working capital — 218 32 (131) (98) 18 (5) (161) (166) (114)
Total debt — 3,226 3,226 3,257 1,648 1,662 1,651 1,592 1,583 1,493
Net debt — 3,045 3,045 3,108 1,537 1,451 1,449 1,467 1,418 1,236
Shareholders’ equity — 638 638 561 2,055 2,256 2,381 1,184 1,114 1,164
Returns, %
Returns, % ROA — (16.81) (3.87) (3.10) (0.43) 2.62 1.39 (21.38) (1.93) 0.17
ROIC — (3.64) 0.00 1.88 3.38 4.49 3.68 (27.83) 0.17 3.14
ROE — (64.86) 0.00 (15.99) (2.02) 7.63 3.92 (71.80) (8.86) 0.80
Negative figures in brackets.

All 10 years →

Fiscal years to Jan 2026 · latest quarter Jul 2026

Charts ten years each

Petco Health and Wellness Company, Inc. vs peers in Specialty Retail (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ARHS Arhaus, Inc. $1.4B 20.0× 13.3× +7.38% (above 0%: growing) +12.00% (above 0%: growing) +130.85% (above 0%: growing) 44.71% 14.10% Compare
EYE National Vision Holdings, Inc. $1.4B 27.7× 22.2× +2.55% (above 0%: growing) +45.45% (above 0%: growing) −133.21% (below 0%: shrinking) 58.23% 4.27% Compare
HZO MarineMax, Inc. $1.2B 291× 77.1× −6.98% (below 0%: shrinking) n/m +0.54% (above 0%: growing) 35.68% 6.09% Compare
WINA Winmark Corporation $1.1B 27.3× 31.8× +23.23% (above 0%: growing) +5.22% (above 0%: growing) −5.68% (below 0%: shrinking) 82.89% 56.60% Compare
WOOF Petco Health and Wellness Company, Inc. $683.1M 21.2× 32.0× +0.05% (above 0%: growing) +180.00% (above 0%: growing) +136.50% (above 0%: growing) 39.70% 3.21%
BWMX Betterware de Mexico SAPI de C $644.0M 8.8× 7.7× +30.92% (above 0%: growing) +28.89% (above 0%: growing) −11.82% (below 0%: shrinking) 65.49% 16.37% Compare
ARKO ARKO Corp. $461.1M 51.3× 25.8× +17.39% (above 0%: growing) −75.00% (below 0%: shrinking) −8.34% (below 0%: shrinking) 12.68% 1.29% Compare
BNED Barnes & Noble Education, Inc $455.9M 19.9× — (loss-making) +0.85% (above 0%: growing) n/m +20.94% (above 0%: growing) 19.63% (5.94%) Compare
EVGO EVgo Inc. $349.1M — (loss-making) — (loss-making) −15.69% (below 0%: shrinking) n/m −232.84% (below 0%: shrinking) 8.88% (48.58%) Compare
Median of peers $887.0M 27.3× 24.0× +4.97% +12.00% −7.01% 40.20% 5.18%

All 49 Specialty Retail stocks →

Petco Health and Wellness Company, Inc. (WOOF) key facts

  • Concern: Petco Health and Wellness Company, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $6.0 billion, down 2.53% from fiscal 2025.
  • Petco Health and Wellness Company, Inc. (WOOF) is a Specialty Retail company in the Consumer Cyclical sector, listed on Nasdaq.
  • As of October 16, 2026, WOOF traded at $2.33, a market capitalization of $683.1 million.
  • Return on equity was 0.80% and debt-to-equity 1.22.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 1.01 (distress zone) for fiscal 2026.

Source: company filings (standardised) and stockrow calculations.

Petco Health and Wellness Company, Inc. (WOOF) Latest News

No news at this impact. Lower the threshold for more.

stockrow.com/WOOF · Data as of Jul 31, 2026 · For information only; not investment advice. · © 2026 stockrow.com